鳳祥股份(9977.HK)大漲近12% 連漲4日 股價創9月以來新高
格隆匯12月8日丨鳳祥股份(9977.HK)盤中一度漲11.9%至3.48港元,已連漲4日,股價創9月16日以來新高,市值48億港元。鳳祥股份是一家白羽肉雞全面一體化企業,公司覆蓋了從上游的飼料生產養殖、屠宰加工以及至下游的雞肉製品的銷售。天風證券最新報告指出,鳳祥股份的核心競爭優勢在於縱向一體化商業模式+C端市場先發優勢+新品研發能力。其中提到,公司前瞻性部署C端,先後以“鳳祥食品”、五更爐“以及”優形“品牌進軍消費者市場。其中,”優形“品牌更是依託健康、美味、時尚的產品定位切入健康零食新藍海。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.